Literature DB >> 29507019

Whipple's disease: a rare case of malabsorption.

Ana Lopes1, Ana Filipa Santos2, Maria Joana Alvarenga1, Alberto Mello E Silva1.   

Abstract

Whipple's disease is a chronic, rare, multisystemic, infectious entity, described for the first time in 1907. Its aetiological agent is the Gram-negative rod, Tropheryma whipplei, which was isolated for the first time in 2001 from a cardiac valve of a patient with endocarditis. We present the case of a 71-year-old man, who came into the emergency room complaining of anorexia, weakness, abdominal pain and diarrhoea with haematochezia and presented disseminated palpable purpuric lesions, predominantly in the lower limbs. The upper endoscopy showed a duodenal vasculitis and the biopsy of that location revealed aspects suggestive of Whipple's disease. We started him on antibiotics according to the recent orientations with progressive clinical and analytical improvement, although he developed an immune reconstitution syndrome, which lasted for 2 weeks. © BMJ Publishing Group Ltd (unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Entities:  

Keywords:  GI bleeding; infection (gastroenterology); malabsorption; vasculitis

Mesh:

Substances:

Year:  2018        PMID: 29507019      PMCID: PMC5847899          DOI: 10.1136/bcr-2017-222955

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  13 in total

Review 1.  Tropheryma whipplei infection and Whipple's disease.

Authors:  Thomas Marth; Verena Moos; Christian Müller; Federico Biagi; Thomas Schneider
Journal:  Lancet Infect Dis       Date:  2016-02-06       Impact factor: 25.071

Review 2.  Whipple's disease: new aspects of pathogenesis and treatment.

Authors:  Thomas Schneider; Verena Moos; Christoph Loddenkemper; Thomas Marth; Florence Fenollar; Didier Raoult
Journal:  Lancet Infect Dis       Date:  2008-03       Impact factor: 25.071

3.  Whipple's disease-generalized stage.

Authors:  Peter Jackuliak; Tomas Koller; Lahim Baqi; Lukas Plank; Zora Lasabova; Gabriel Minarik; Juraj Payer
Journal:  Dig Dis Sci       Date:  2008-06-04       Impact factor: 3.199

Review 4.  New insights into Whipple's disease and Tropheryma whipplei infections.

Authors:  Benoit Desnues; Khatoun Al Moussawi; Florence Fenollar
Journal:  Microbes Infect       Date:  2010-08-11       Impact factor: 2.700

5.  Prevalence of Whipple's disease in north-western Italy.

Authors:  F Biagi; D Balduzzi; P Delvino; A Schiepatti; C Klersy; G R Corazza
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-03-25       Impact factor: 3.267

6.  Systemic Tropheryma whipplei: clinical presentation of 142 patients with infections diagnosed or confirmed in a reference center.

Authors:  Jean-Christophe Lagier; Hubert Lepidi; Didier Raoult; Florence Fenollar
Journal:  Medicine (Baltimore)       Date:  2010-09       Impact factor: 1.889

7.  Failure and relapse after treatment with trimethoprim/sulfamethoxazole in classic Whipple's disease.

Authors:  Jean-Christophe Lagier; Florence Fenollar; Hubert Lepidi; Didier Raoult
Journal:  J Antimicrob Chemother       Date:  2010-07-17       Impact factor: 5.790

8.  Tropheryma whipplei, the Whipple's disease bacillus, induces macrophage apoptosis through the extrinsic pathway.

Authors:  L Gorvel; K Al Moussawi; E Ghigo; C Capo; J-L Mege; B Desnues
Journal:  Cell Death Dis       Date:  2010-04-08       Impact factor: 8.469

9.  Value of Tropheryma whipplei quantitative polymerase chain reaction assay for the diagnosis of Whipple disease: usefulness of saliva and stool specimens for first-line screening.

Authors:  Florence Fenollar; Sonia Laouira; Hubert Lepidi; Jean-Marc Rolain; Didier Raoult
Journal:  Clin Infect Dis       Date:  2008-09-01       Impact factor: 9.079

10.  Efficacy of ceftriaxone or meropenem as initial therapies in Whipple's disease.

Authors:  Gerhard E Feurle; Natascha S Junga; Thomas Marth
Journal:  Gastroenterology       Date:  2009-10-29       Impact factor: 22.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.